Article

Urodynamics

Presented by Philip M. Hanno, MD, University of Pennsylvania, Philadelphia.

Newsletter

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Subscribe Now!
Related Videos
Doctor talking with patient | Image Credit: © Pcess609 - stock.adobe.com
TRT delivery: A urologist discusses options and patient preferences
Joseph Song, MD, describes his experience using the CVAC device
Joseph Song, MD, describes his experience using the CVAC device
Experts assess pre-operative factors linked with buccal mucosa graft failure
Experts assess pre-operative factors linked with buccal mucosa graft failure
Interim Results from ADVANCED 2
Interim Results from ADVANCED 2
DNA molecules | Image Credit: © vitstudio - stock.adobe.com
Integrating ctDNA in NMIBC: Promise and practical challenges
TARA-002 mechanism of action
TARA-002 mechanism of action
Robert Jansen, MD, answers a question during a Zoom video interview
Robert Jansen, MD, discusses evaluation of candidates for testosterone therapy
Ashley Winter, MD, discusses testosterone therapy for women
Ashley Winter, MD, discusses testosterone therapy for women
Vikram Narayan, MD, on embracing thoughtful tech adoption
Vikram Narayan, MD, on embracing thoughtful tech adoption
Blur image of hospital corridor | Image Credit: © zephyr_p - stock.adobe.com
Eating disorders and pelvic health: What clinicians need to know
Related Content
Pembrolizumab plus axitinib shows sustained benefit vs sunitinib in ccRCC
August 4th 2025

Pembrolizumab plus axitinib shows sustained benefit vs sunitinib in ccRCC

Hannah Clarke
Five-year data from the phase 3 KEYNOTE-426 trial confirm the clinical benefits of front-line pembrolizumab plus axitinib in advanced ccRCC.
Pearls & Perspectives: Tailoring BPH Therapies to the Patient, with Utsav Bansal, MD
August 4th 2025

Pearls & Perspectives: Tailoring BPH Therapies to the Patient, with Utsav Bansal, MD

Amy M. Pearlman, MD
Bansal unpacks how to personalize treatment plans in a therapeutic landscape now filled with minimally invasive and surgical options.
Medical Bill Codes and Spreadsheet Data | Image Credit: © Andrey Popov - stock.adobe.com
August 4th 2025

How to bill for mitomycin for intravesical solution in NMIBC

Jonathan Rubenstein, MD Mark Painter
"As with all medications and services, it is important to check with the patient’s insurer to determine their policy and whether the medication will be covered," write Jonathan Rubenstein, MD, and Mark Painter.
Pearls & Perspectives: Testosterone and the Future of Men’s Health, with John P. Mulhall, MD
August 4th 2025

Pearls & Perspectives: Testosterone and the Future of Men’s Health, with John P. Mulhall, MD

Amy M. Pearlman, MD
Mulhall offers an unfiltered, evidence-based deep dive into testosterone evaluation and treatment nuances.
FDA updates in urology: July 2025
August 4th 2025

FDA updates in urology: July 2025

Hannah Clarke
A recap of the FDA submissions and regulatory decisions in urology from July 2025.
SunRISe-1 data of TAR-200 in NMIBC published in Journal of Clinical Oncology
August 4th 2025

SunRISe-1 data of TAR-200 in NMIBC published in Journal of Clinical Oncology

Hannah Clarke
Data show that TAR-200 monotherapy led to high complete response rates and encouraging DFS in patients with BCG-unresponsive high-risk NMIBC.
© 2025 MJH Life Sciences

All rights reserved.